The prognostic effect of p140Cap was finally underlined in this subgroup of ERBB2-amplified breast cancer patients, where the Kaplan–Meier analysis of these tumors evidenced that SRCIN1 amplification is associated with a significant improved survival and an high expression of p140Cap predict a lower probability of developing metastasis. This evidence concerns the gene ERBB2 and breast carcinoma.